Introduction
============

During the last decade, the rate of nosocomial infections caused by multidrug-resistant *Acinetobacter baumannii* (MDRAB) has increased worldwide. In particular, the growing number of carbapenem-resistant *A. baumannii* isolates, mainly due to the production of carbapenem-hydrolyzing class D β-lactamases (CHDLs) jeopardizes the treatment of infections caused by this agent ([@B16]). The quick and reliable clonality assessment is crucial to rapidly trace its dissemination, assist antibiotherapy, and implement measures to constrain its dissemination.

Pulsed-field gel electrophoresis (PFGE), amplified fragment length polymorphism (AFLP) analysis, multilocus sequence typing (MLST), Diversilab^TM^ typing, other PCR fingerprinting methods, and multiple-locus variable tandem repeat number analysis (MVLA) are among the current methods used for genotyping bacteria ([@B15]; [@B17]; [@B30]; [@B31]). PCR and sequence-based methods which describe isolates numerically are easy to use in international networks. Specifically for *A. baumannii,* Sequence Groups (SGs) identification or Trilocus ([@B27]) sequence-based typing (3LST -- selectively amplifies alleles of *omp*A, *csu*E, and *bla*~OXA-51~ genes), *bla*~OXA-51-like~ genotyping and two MLST schemes^[1](#fn01){ref-type="fn"}^ ("Oxford" and Institute Pasteur) are available. The 3LST, *bla*~OXA-51-like~ genotyping, and Diversilab^TM^ typing (which consists in a repetitive extragenic palindromic PCR -- rep-PCR) allow the rapid identification of the main multidrug-resistant *A. baumannii* lineages, being already established the concordance between some of these methods ([@B31]). The MLST schemes share three loci but reveal different discriminatory abilities, with our data pointing for a higher resolution, congruent to PFGE analysis and CHDL content, of the "Oxford" scheme ([@B15]). MLST analysis in several collections resulted in the recognition of major clonal complexes (CCs) and sequence types (STs) responsible for antimicrobial resistance dissemination, such as CC92 (ST92, ST208, ST218), CC109 (ST109), CC103 (ST103, ST133), and CC113 (ST113) according with the Oxford scheme ([@B31]).

However, most of these methods are too expensive and/or time consuming. Spectroscopic techniques might constitute reliable alternatives for bacterial typing at different taxonomic levels, with variable degrees of success reported from their application to several microorganisms ([@B20]; [@B23]; [@B28]; [@B4],[@B5]; [@B21]; [@B25]). Recently, we developed and validated a mathematical model for typing *A. baumannii* clones, most of them included in this study, based on spectra obtained by a competitive spectroscopic technique, Fourier transform infrared spectroscopy with attenuated total reflectance (FTIR-ATR), that could be routinely used ([@B26]). Moreover, using matrix assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and chemometrics we were able to circumvent difficulties associated with the discrimination by MALDI-TOF MS of *Acinetobacter* species within the *A. baumannii-calcoaceticus* complex ([@B3]; [@B10]; [@B25]). In which concerns the suitability of MALDI-TOF MS for bacterial typing at subspecies level, controversial data is available ([@B1]; [@B9]; [@B11]; [@B18]; [@B21]; [@B29]).

In this work, we evaluated the ability of MALDI-TOF MS combined with several chemometric tools for assisting infection control by depicting *A. baumannii* clones.

Materials and Methods {#s1}
=====================

Rational of the Study
---------------------

To evaluate the potential of MALDI-TOF MS to discriminate *A. baumannii* clones, mass spectra of 58 Portuguese clinical isolates belonging to ST98, ST103, ST208, and ST218 according with the "Oxford" scheme were obtained and analyzed with several chemometric tools. Mass profiles analysis was performed by different approaches: (i) spectral overview on the basis of pseudo gel views; (ii) analysis of the mass peak pattern according the number of peaks found with the Matlab function *peakfind*; and (iii) partial least squares discriminant analysis (PLSDA). The last two approaches also allowed the estimative of correct predictions for each ST and the PLSDA model was performed considering the entire (2--20 kDa) and a selected (4--10 kDa) spectral range where the majority of the mass peaks (about 90%) were located. Additionally, mass spectra of 38 isolates from different countries and belonging to 22 distinct STs were obtained and the respective pseudo gel views compared among each other and with the ones of ST98, ST103, ST208, and ST218 isolates. We further explored a possible correlation between the mass profiles of the isolates tested and clustering/classification obtained with other methods for major lineages *A. baumannii* identification, as AFLP, SG typing, and the MLST scheme of Institute Pasteur.

Bacterial Isolates
------------------

Fifty-eight *A. baumannii* clinical isolates were selected among a previously published collection of 318 CHDL-producing *Acinetobacter* spp. recovered from six geographically distant Portuguese hospitals (2001--2012). The selected isolates are representatives of the main lineages disseminated in Portugal before 2012: ST98 (*n* = 10); ST103 (*n* = 9); ST208 (*n* = 17; corresponding to a reassignment of ST92 isolates), and ST218 (*n* = 22; [@B14],[@B15]; [@B26]). Additionally, 38 isolates belonging to 22 different STs were used for further comparisons. The main characteristics of the isolates used in this study, including the relationship between CHDL content, PFGE types, SGs, and the STs obtained according with Institute Pasteur and "Oxford" scheme^1^ among others were presented in **Table [1](#T1){ref-type="table"}**.

###### 

Epidemiological details of the *Acinetobater baumannii* isolates included in this study.

  ST (CC)^b^   ST (CC)^c^   SG (AFLP)^a^                *n*^d^   PFGE^e^   CHDL^f^   Country            Years        Reference
  ------------ ------------ --------------------------- -------- --------- --------- ------------------ ------------ --------------------
  98 (92)      2 (2)        SG1 (II)                    10       A         OXA-40    Portugal           2001--2008   [@B15], [@B26]
  208 (92)     2 (2)        SG1 (II)                    17       A4        OXA-23    Portugal           2006--2010   [@B15], [@B26]
  218 (92)     2 (2)        SG1 (II)                    22       A5        OXA-23    Portugal           2010         [@B26]; This study
  103 (103)    15 (15)      SG5                         9        B, C      OXA-58    Portugal           2001--2004   [@B15], [@B26]
  15                        G1ompA/G2csuE               1        O         \-        Germany            1991         [@B24], [@B26]
  16                        SG2 (I)                     1        L         \-        Germany            1991         [@B24], [@B26]
  113 (113)    79 (79)      SG1 (II)                    4        D         OXA-23    Brazil             2006--2007   [@B14]
  132          162          G1~OXA66~/G2~ompA~/~csuE~   2        F         OXA-23    Brazil             2007         [@B14]
  133 (103)    15 (15)      SG4                         3        E         OXA-23    Brazil             2006--2007   [@B14]
  134          316          G2~ompA~/~OXA69~            1        K         OXA-23    Brazil             2007         [@B14]
  195                       SG1 (II)                    1        P         OXA-23    Germany            2010         [@B26]
  231                       G2~OXA-69~/~ompA~           2        J, X      OXA-23    Germany, Italy     2004--2012   [@B26]
  236                       SG1 (II)                    1        T         \-        Italy              2012         This study
  348                       SG1 (II)                    1        R         OXA-72    Croatia            2001--2007   [@B13], [@B26]
  391                       G1~ompA~                    1        U         \-        Germany            2012         [@B26]
  437 (92)     2 (2)        SG1 (II)                    5        A4        OXA-58    Italy              2004--2008   [@B7], [@B26]
  439                       SG2 (I)                     1        M         \-        Germany            1991         [@B24], [@B26]
  441                       SG2 (I)                     4        H         \-        Germany, Croatia   2001--2007   [@B26]
  513 (92)     2 (2)        SG1 (II)                    2        A5        OXA-23    Italy              2007--2009   [@B8], [@B26]
  514                       G1~csuE~/G2~OXA-69~         1        N         \-        Germany            1991         [@B26]
  515                                                   1        I         \-        Portugal           2010         [@B26]
  732                       G1~ompA~                    2        V, W      \-        Germany            2012         [@B26]
  733                       G1~ompA~                    1        Y         OXA-23    Germany            2012         [@B26]
  740                       SG2 (I)                     1        Q         \-        Croatia            2001--2007   [@B26]
  775                       SG2 (I)                     1        G         \-        Croatia            2001--2007   [@B26]
  776                       G1~OXA66~/~ompA~/G2~csuE~   1        S         \-        Italy              2012         [@B26]

a

SG, sequence group typing (PCR-based sequence groups based on

ompA

,

csuE,

and

bla

OXA-51

genes); AFLP, amplified fragment length polymorphism correspondence to international clones I--III);

b

Sequence Type (ST) and Clonal Complex (CC) determined according with the "Oxford" scheme;

c

Sequence Type (ST) and Clonal Complex (CC) determined according with Institut Pasteur MLST scheme;

d

n

total of isolates;

e

ApaI-Pulsed Field Gel Electrophoresis type;

f

CHDL, acquired carbapenem-hydrolyzing class D β-lactamase.

MALDI-TOF MS Experiments
------------------------

Mass spectra were obtained from cell extracts prepared according the manufacturer instructions. Briefly, overnight cultures in Muller-Hinton agar were suspended in HPLC water and treated with ethanol (75%). After centrifugation and removal of the supernatant, cells were extracted with 25 μL of 70% formic acid followed by addition of 25 μL of acetonitrile and vortexing at 2000 rpm for 1 min. Samples were spotted onto MALDI ground steel target (AnchorChip) followed by drying and the addition of 1 μL of the chemical matrix (saturated solution of α-cyano-4-hydroxycinnamic acid in 50% of acetonitrile and 2.5% of trifluoroacetic acid). Spectra were randomly obtained from blind samples in the linear positive mode at a laser (nitrogen) frequency of 20 Hz in the range of 2--20 kDa with a Microflex III instrument (Bruker Daltonic, Bremen, Germany). Each recorded spectrum is the result of six series of 40 single laser shots in different locations. The experiments were performed in quadruplicate using four distinct spots of the MALDI target (instrumental replicates) at least in two different days (biological replicates) with two different bacterial cultures or extracts. External calibration of the mass spectra was performed using *Escherichia coli* DH5 alpha standard peaks (BTS).

Data Analysis
-------------

Due to the large amount of data generated by MALDI experiments, mean spectrum for each isolate was generated from the instrumental and biological replicates and considered for further analysis. Zero-line and low S/N ratio mass spectra were not considered to the average. The pseudo gel views were generated by the dedicated Matlab-based software MicrobeMS^[2](#fn02){ref-type="fn"}^ that provides direct access to the spectra of Bruker's proprietary file format. In these gel views the intensities are gray-scaled (log scale) being the mass/charge ratios (m/z) the abscissa and spectral indices the ordinate values. In these bar code spectra only the information of peak presence or absense is employed, while the peak intensity is neglected.

Mass spectra were also analyzed with the *peakfind* function of the PLS Toolbox for Matlab (arguments: 9- number of points in Savitzky--Golay filter, 6- tolerance on the estimated residuals; peaks heights are estimated to be \>tolerance^∗^residuals) and 19- window width for determining local maxima to evaluate the intra and inter-ST variability among the four distinct STs. The method starts by estimating the peak mass-to-charge ratios of each ST. For this task, spectra of all isolates belonging to one ST were averaged, the result was submitted to the peak identification method and the peak locations were stored in a vector generating a "peak prototype" for each ST. This method was repeated for all STs. Then, the same peak identification method was run for each isolate individually. Peak positions of each "ST prototype" were compared with peak positions of each isolate. When a "ST prototype" peak location matched a peak location of an isolate, a value 1 was assigned for that peak; otherwise a value 0 was assigned. This procedure creates a vector of 0s and 1s for each pair "ST prototype"/isolate. Note that peak locations were considered to match if they were located within a mass-to-charge ratio difference lower than 7 m/z units \[if for a certain peak location *n*, \| m/z(prototype)~n~--m/z(sample)~n~\| \< 7, that peak is considered to match\]. For each isolate, a percentage of matching peaks was estimated for each ST. Isolates were considered to belong to the ST yielding the highest percentage of peak matches.

For clustering purposes spectra were analyzed by PLSDA after the pre-processing mean-centring ([@B22]; [@B12]; [@B2]). This pre-processing method allows removing the influence of different sample amounts and/or equipment variations in the peaks intensity. In PLSDA, to each known sample (*x~i~*) is assigned a vector of 0s with the value 1 at the position corresponding to its ST (*y~i~*). The structure of the PLSDA model is described by Eqs 1 and 2. Model loadings (*P* and *Q*) and corresponding scores (*T* and *U*) are obtained by sequentially extracting the components or latent variables (LVs) from matrices *X* (the spectra) and *Y* (the matrix codifying the STs).
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The algorithm correlates the scores of each block (*T* and *U*), yielding an internal regression matrix. This internal regression can be transformed on a regression matrix (*B*). In this case, the regression matrix is composed by three vectors: one regression vector corresponding to each ST. *E* and *F* are the residual matrices and depend on the number of LV selected. Predictions for new samples are obtained by multiplying a new spectrum (*x~new~*) by the regression matrix (*B*).
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The prediction (y~new~ = \[y~new,1,~y~new,2,~\....~,~y~new,n~\]) is then converted in a class assignment. In PLSDA a probability value for each assignment is estimated for each sample. The model number of LV was optimized using the leave-one-sample-out cross-validation procedure in order to prevent overfitting. All chemometric models were performed in Matlab version 7.4 Release 2007a (MathWorks, Natick, MA, USA) and PLS Toolbox version 4.2.1 for Matlab (Eigenvector Research, Manson, WA, USA).

Results
=======

Spectral Overview
-----------------

Mean mass profiles of the isolates belonging to the four studied STs are presented in **Figure [1](#F1){ref-type="fig"}**. A very similar peak pattern can be found among the isolates of a single ST (data not shown) and among the four STs with almost no differences between them. The common peaks found among the four STs are summarized in the figure. **Figure [2](#F2){ref-type="fig"}** exhibits the pseudo gel views generated with MicrobeMS software considering all the isolates included in this study (ST98, S103, ST208, ST218 plus the 22 STs of the international collection). A high degree of consistency in the peak pattern can be found among the isolates of a single ST but also among the four STs (**Figure [2A](#F2){ref-type="fig"}**). It was impossible to obtain any degree of isolate discrimination according the ST solely based in the presence and/or absence of specific mass peak profiles even considering isolates epidemiologically unrelated and belonging to diverse STs (**Figure [2B](#F2){ref-type="fig"}**).

![**Mass profiles of ST98, ST103, ST208, and ST218 isolates in the region of 2--13 kDa \[obtained from the mean spectra of each sequence types (ST)\]**.](fmicb-06-00481-g001){#F1}

![**Pseudo gel view representation obtained from the average mass spectra of each *Acinetobacter baumannii* isolate of ST98, ST103, ST208, and ST218 **(A)** and of *A. baumannii* isolates of the international collection (B)**.](fmicb-06-00481-g002){#F2}

Peakfind Function of Matlab
---------------------------

Supplementary Figure [S1](#SM1){ref-type="supplementary-material"} summarizes the peak positions founded with the *peakfind* function in the mass spectra from all isolates. No peaks were found above 17 kDa. Similarly to the observations in the pseudo gel view analysis, a very consistent peak pattern was observed among all the isolates with a low inter and intra-ST spectral variability. The comparison of each isolate peak profile with the four mean-ST peak profiles (see Materials and Methods) was used for estimating the ST of each isolate, **Figure [3](#F3){ref-type="fig"}**. Nevertheless, it was only possible to correctly predict the ST for 58.6% of the isolates. ST103 isolates were always correctly predicted; however, 19/58 isolates were erroneously predicted as ST103, meaning a high sensitivity (9/9 = 100%) and low specificity (30/51 = 58.8%) for the ST103 prediction. Moreover, it was possible to correctly predict 70% of the ST98 isolates; 41.2% of the ST208 isolates and 50% of the ST218 isolates.

![**Sequence type assignments for all isolates considering the spectral matching method.** Colors identify the real ST of each isolate and bars correspond to the method's ST predictions (58.6% of correct predictions). Legend: ![](fmicb-06-00481-i001.jpg) ST98, ![](fmicb-06-00481-i002.jpg) ST103, ![](fmicb-06-00481-i003.jpg) ST208, and ![](fmicb-06-00481-i004.jpg) ST218.](fmicb-06-00481-g003){#F3}

Partial Least Squares Discriminant Analysis
-------------------------------------------

The PLSDA models developed considering the entire (2--20 kDa) and a selected (4--10 kDa) spectral range are presented in **Figures [4A,B](#F4){ref-type="fig"}**, respectively. Considering the entire spectral range (**Figure [4A](#F4){ref-type="fig"}**) it was not possible to clearly discriminate the four STs as no individualized clusters could be found in the score map of the model. The PLSDA model was able to correctly predict the STs of 64.6% of the isolates (**Table [2](#T2){ref-type="table"}**) being ST103 the one with a larger percentage of correct predictions (75.7%). The worst cases were observed for ST98 and ST208 for which plus than 40% of the isolates were erroneously predicted. Similarly, the PLSDA model obtained with the selected spectral range (4--10 kDa) did not allow the discrimination of the four STs (**Figure [4B](#F4){ref-type="fig"}**) still being ST103 the best predicted (73.7%), **Table [2](#T2){ref-type="table"}**. Moreover, the total percentage of correct predictions was slightly higher (65.8%) for each of the three remaining STs considering the 4--10 kDa range.

![**Score plot corresponding to the first three latent variables (LVs) of the partial least squares discriminant analysis (PLSDA) regression model using the entire, 2--20 kDa, **(A)** and a selected, 4--10 kDa, **(B)** spectral range.** Legend: ![](fmicb-06-00481-i005.jpg) ST98, ![](fmicb-06-00481-i006.jpg) ST103, ![](fmicb-06-00481-i007.jpg) ST208, and ![](fmicb-06-00481-i008.jpg) ST218.](fmicb-06-00481-g004){#F4}

###### 

Confusion matrix for both of the *A. baumannii* PLSDA discrimination models, considering 20 LV (values are in %).

                                         ST obtained with MLST^(a)^                                             
  ------------------------------ ------- ---------------------------- ------ ------ ------ ------ ------ ------ ------
  ST predicted by MALDI-TOF MS   ST98    56.2                         5.7    12.6   14.4   56.6   8.1    13.1   12.7
                                 ST103   3.5                          75.7   5.3    2.3    2.8    73.7   4.7    3.2
                                 ST208   17.2                         8.8    56.8   13.7   19.5   10.0   60.6   13.6
                                 ST218   23.1                         9.8    25.3   69.6   21.1   8.2    21.5   70.4

a

Sequence type determined according with "Oxford" scheme (

http://pubmlst.org/abaumannii/

).

Partial least squares discriminant analysis models were also developed (whenever possible and according to the available information, please see **Table [1](#T1){ref-type="table"}**) to correlate the mass profiles of the isolates with the results obtained from less discriminatory typing methods as AFLP, SG, and MLST scheme of Institute Pasteur. However, the clustering analysis was not congruent with any of these methods (data not shown).

Discussion
==========

In the last years an impressive growing number of studies unveiling the MALDI-TOF MS potential for routine bacterial species identification has been published ([@B3]; [@B6]; [@B4],[@B5]; [@B25]). However, the suitability of this mass spectrometry technique for bacterial discrimination at the subspecies level has been barely explored, with contradictory outcomes for particular species ([@B1]; [@B9]; [@B29]; [@B11]; [@B18]; [@B21]). The goal of this work was to assess the ability of MALDI-TOF MS to depict *A. baumannii* clones, with particular interest for the worldwide spread lineages (ST98, ST103, ST208, and ST218), contributing to a better understanding of the capabilities and limitations of this technique in bacterial typing. Analysis of the mass spectra of the four STs was attempted using three approaches and revealed some mass-to-charge ratios already identified as *Acinetobacter* genus and *A. baumannii* species-specific ([@B3]; [@B10]; [@B23]; [@B25]). However, the high similarity among mass profiles of the *A. baumannii* lineages analyzed prevented the STs discrimination either by peak pattern direct analysis (**Figure [1](#F1){ref-type="fig"}**) or based on the presence/absence of specific peaks depicted in the pseudo gel views (**Figure [2A](#F2){ref-type="fig"}**). Moreover, attempting to assign a ST based on the comparison of each isolate's mass profile with the mean-ST profile also resulted in a low percentage of correct identifications (58%, **Figure [3B](#F3){ref-type="fig"}**). Previous studies, including from our group ([@B21]; [@B25]), have demonstrate that the use of specific and optimized chemometric tools in MALDI-TOF MS data analysis improves the bacterial discrimination derived from this spectroscopic methodology. In this context, we attempted to discriminate the isolates with a PLSDA analysis considering two distinct mass ranges (**Figures [4A,B](#F4){ref-type="fig"}**). Although the degree of discrimination slightly improved, only 64.6 and 65.8% of correct STs predictions were obtained for the two considered mass ranges, demonstrating the current inadequacy of MALDI-TOF MS for discrimination of major *A. baumannii* STs. The difficulty to differentiate these STs based on MALDI-TOF MS analysis could possibly be associated with the relatedness of their allelic profiles. In fact, ST98 is a double locus variant of ST208 and ST218 in *gyrB* and *gpi* and ST208 a single locus variant of ST218 in the *gpi* allele. Despite the low ability to discriminate the four STs, *A. baumannii* ST103 isolates always presented the higher rate of correct ST predictions whether considering the comparison of the ST-mean mass profiles or the chemometric approach. It is of note that the allelic profile of ST103 isolates is the most dissimilar one, presenting only one common allele with ST98, the *gpi* one^[3](#fn03){ref-type="fn"}^. This fact could contribute to a more dissimilar ribosomal protein/peptide profile of ST103 isolates and its subsequent higher rate of correct identifications. The difficulty to differentiate these four STs based on their mass spectra suggests that these clones possess a very similar profile in what concerns to the molecules routinely observed in these MALDI experiments.

As a high throughput technique, MALDI-TOF MS competes with other spectroscopic techniques as Raman ([@B19]), and Fourier Transform Infrared Spectroscopy (FTIR) for bacterial typing at different taxonomic levels. It is of note, the suitability of FTIR to discriminate *A. baumannii* lineages, including the STs included in this study ([@B26]), which is also a sensitive, quick and low cost technique. Nevertheless, with the recognition of the interest in the microbiological diagnostic of MALDI-TOF MS, associated with the increasing availability of MALDI-TOF MS equipment in routine laboratories, there is a particular interest on methodology developments assisting bacterial epidemiology. In this way, further assays testing the ability of MALDI-TOF MS to discriminate *A. baumannii* lineages with different sample preparation conditions and matrix solutions should be conducted. It also should be noted that, despite our MALDI data had been compared with four distinct classification methods (two different MLST schemes, AFLP and SG), presenting different typing resolutions, it was not congruent with the grouping obtained with any of these approaches. In this way, it does not offer, in these experimental conditions, an advantage over other rapid methods such as DiversiLab rep-PCR-based typing, trilocus sequence-based typing, or single-locus-sequence-based typing of *bla*~OXA-51~-like genes. However, we do not exclude the possibility that other classification method could somehow fit MALDI-TOF MS data.

Conclusion
==========

In this work we evaluate the ability of MALDI-TOF MS to discriminate *A. baumannii* clones. This mass spectroscopic technique, which revealed in previous studies a high discrimination power for species identification within the *A. calcoaceticus--A. baumannii* complex, demonstrates an insufficient result when used for discrimination at the clonal level. These findings suggest that the detected molecules, mainly ribosomal peptides and/or proteins, remain unchanged during clonal diversification in this species. Further studies, namely using different sample preparation conditions, are needed to provide further insights on the suitability of MALDI-TOF MS for typing *A. baumannii* at a subspecies level.
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